Peptide-mediated cellular delivery of antisense oligonucleotides and their analogues

Cellular and Molecular Life Sciences

Volumn 60, Issue 5, 2003, Pages 844-853

  Gait, Michael J ^a  

^a MRC LABORATORY OF MOLECULAR BIOLOGY   (United Kingdom)

Author keywords

Antisense; Conjugates; Oligonucleotides; Peptides; PNA

Indexed keywords

ANION; ANTISENSE OLIGODEOXYNUCLEOTIDE; ANTISENSE OLIGONUCLEOTIDE; ASIALOGLYCOPROTEIN; CATION; CELL RECEPTOR; CHLOROQUINE; DRUG CARRIER; ESTER DERIVATIVE; FIXATIVE; GLYCINE DERIVATIVE; HYBRID PROTEIN; INTERLEUKIN 6; LUCIFERASE; MESSENGER RNA; N (2 AMINOETHYL)GLYCINE; NANOPARTICLE; PENETRATIN; PEPTIDE; PEPTIDE NUCLEIC ACID; PHOSPHODIESTER; PHOSPHOROTHIOIC ACID; POLYLYSINE; PROTAMINE; SIGNAL PEPTIDE; SURFACTANT; SYNTHETIC PEPTIDE; TRANSACTIVATOR PROTEIN; TRANSPORTAN; UNCLASSIFIED DRUG; UNINDEXED DRUG; VIRUS HEMAGGLUTININ;

ADSORPTION; AMINO ACID SEQUENCE; ANIMAL CELL; ANTIVIRAL ACTIVITY; CELL COMPARTMENTALIZATION; CELL CULTURE; CELL MEMBRANE PERMEABILITY; CELL PROTECTION; CELLULAR DISTRIBUTION; COMPLEMENT ACTIVATION; COMPLEX FORMATION; CONJUGATE; COVALENT BOND; CYTOTOXICITY; DNA TRANSFECTION; DRUG CONJUGATION; DRUG DELIVERY SYSTEM; DRUG LABELING; DRUG SAFETY; DRUG STABILITY; DRUG STRUCTURE; DRUG SYNTHESIS; DRUG TARGETING; DRUG UPTAKE; ENDOCYTOSIS; ENDOPLASMIC RETICULUM; ENDOSOME; EUKARYOTIC CELL; FLUORESCENCE; GENE CONTROL; GENE EXPRESSION REGULATION; GENE TARGETING; GENE TRANSFER; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IN VIVO STUDY; INTRACELLULAR TRANSPORT; LOW TEMPERATURE; MEMBRANE TRANSPORT; MOLECULAR WEIGHT; NONHUMAN; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN NUCLEIC ACID INTERACTION; PROTEIN STRUCTURE; PROTEIN TARGETING; REVIEW; SIGNAL TRANSDUCTION; STOICHIOMETRY; TARGET CELL; TEMPERATURE DEPENDENCE; VESICULAR STOMATITIS VIRUS; VIRUS INFECTION;

ANIMALIA; EUKARYOTA; VESICULAR STOMATITIS VIRUS;

EID: 0037600638     PISSN: 1420682X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00018-003-3044-5     Document Type: Review

References (75)

1. Opalinska J. B. and Gewirtz A. M. (2002) Nucleic-acid therapeutics: basic principles and recent applications. Nature Rev. 1: 503-514
2. Chadwick D. J. and Cardew G. (1997) Oligonucleotides as Therapeutic Agents, John Wiley, Chichester
3. Stein C. A. and Krieg A. M. (1998) Applied Antisense Technology, Wiley-Liss, New York
4. Dean N. M. (2001) Functional genomics and target validation approaches using antisense oligonucleotide technology. Curr. Opin. Biotechnol. 12: 622-625
5. Bennett C. F., Chiang M.-Y., Chan H., Shoemaker J. E. E. and Mirabelli C. K. (1992) Cationic lipids enhance cellular uptake and activity of phosphorothioate antisense oligonucleotides. Mol. Pharmacol. 41: 1023-1033
6. Langel U. (2002) Cell Penetrating Peptides: Processes and Applications, CRC Press, Boca Raton, FL
7. Fischer P. M., Krausz E. and Lane D. P. (2001) Cellular delivery of impermeable effector molecules in the form of conjugates with peptides capable of mediating membrane translocation. Bioconj. Chem. 12: 825-841
8. Lindsay M. A. (2002) Peptide-mediated cell delivery: application in protein target validation. Curr. Opin. Pharmacol. 2: 587-594
9. Morris M. C., Chaloin L., Heitz F. and Divita G. (2000) Translocating peptides and proteins and their use for gene delivery. Curr. Opin. Biotechnol. 11: 461-468
10. Derossi D., Joliot A. H., Chassaing G. and Prochiantz A. (1994) The third helix of the Antennapedia homeodomain translocates through biological membranes. J. Biol. Chem. 269: 10444-10450
11. Derossi D., Chassaing G. and Prochiantz A. (1998) Trojan peptides: the penetratin system for intracellular delivery. Trends Cell Biol. 8: 84-87
12. Vivès E., Brodin P. and Lebleu B. (1997) A truncated HIV-1 Tat protein basic domain rapidly translocates through the plasma membrane and accumulates in the cell nucleus. J. Biol. Chem. 272: 16010-16017
13. Fawell S., Seery J., Daikh Chen L.L., Pepinsky B. and Barsoum J. (1994) Tat-mediated delivery of heterologous proteins into cells. Proc. Natl. Acad. Sci. USA 91: 664-668
14. Wadia J. S. and Dowdy S. F. (2002) Protein transduction technology. Curr. Opin. Biotechnol. 13: 52-56
15. Torchilin V. P., Rammohan R., Weissig V. and Levchenko T. S. (2001) Tat peptide on the surface of liposomes afford their efficient intracellular delivery even at low temperature and in the presence of metabolic inhibitors. Proc. Natl. Acad. Sci. USA 98: 8786-8791
16. Eguchi A., Akuta T., Okuyama H., Senda T., Yokoi H., Inokuchi H. et al. (2001) Protein transduction domain of HIV-1 Tat protein promotes delivery of DNA into mamalian cells. J. Biol. Chem. 276: 26204-26210
17. Schwarze S. R., Ho A., Vocero-Akbani A. and Dowdy S. F. (1999) In vivo protein transduction: delivery of a biologically active protein into the mouse. Science 285: 1569-1572
18. Polyakov V., Sharma V., Dahlheimer J. L., Pica C. M., Luker G. D. et al. (2000) Novel Tat-peptide chelates for direct transduction of technetium-99m and rhenium into human cells for imaging and radiotherapy. Bioconjugate Chem. 11: 762-771
19. Lewin M., Carlesso N., Tung C.-H., Tang X.-W., Cory D., Scadden D. T. et al. (2000) Tat peptide-derivatized magnetic nano-particles allow in vivo tracking and recovery of progenitor cells. Nat. Biotech. 18: 410-414
20. Lee H. J. and Pardridge W. M. (2001) Pharmacokinetics and delivery of Tat and Tat-protein conjugates to tissues in vivo. Bioconjugate Chem. 12: 995-999
21. Silhol M., Tyagi M., Giacci M., Lebleu B. and Vivès E. (2002) Different mechanisms for cellular internalization of the HIV-1 Tat-derived cell penetrating peptide and recombinant proteins fused to Tat. Eur. J. Biochem. 269: 494-501
22. Pooga M., Soomets U., Hällbrink M., Valkna A., Saar K., Rezaei K. et al. (1998) Cell penetrating PNA constructs regulate galanin receptor levels and modify pain transmission in vivo. Nat. Biotech. 16: 857-861
23. Wadhwa M. S., Collard W. T., Adami R. C., Mckenzie D. L. and Rice K. G. (1997) Peptide-mediated gene delivery: influence of peptide structure on gene expression. Bioconj. Chem. 8: 81-88
24. McGregor C., Perrin C., Monck M., Camillieri P. and Kirby A. J. (2001) Rational approches to the design of cationic gemini surfactants for gene delivery. J. Am. Chem. Soc. 26: 6215-6220
25. Wyman T. B., Nicol F., Zelphati O., Scario P. V., Plank C. and Szoka F. C. (1997) Design, synthesis and characterization of a cationic peptide that binds to nucleic acids and permeabilizes bilayers. Biochemistry 36: 3008-3017
26. Niidome T., Ohmori N., Ichinose A., Wada A., Mihara H., Hirayama T. et al. (1997) Binding of cationic a-helical peptides to plasmid DNA and their gene transfer abilities into cells. J. Biol. Chem. 272: 15307-15312
27. Midoux P., Kichler A., Boutin V., Maurizot J.-C. and Monsigny M. (1998) Membrane permeabilization and efficient gene transfer by a peptide containing several histidines. Bioconj. Chem. 9: 260-267
28. Junghans M., Kreuter J. and Zimmer A. (2000) Antisense delivery using protamine-oligonucleotide particles. Nucleic Acids Res. 28: e45
29. Pichon C., Freulon I., Midoux P., Mayer R., Monsigny M. and Roche A.-M. (1997) Cytosolic and nuclear delivery of oligonucleotides mediated by an amphiphilic anionic peptide. Antisense Nucleic Acid Drug Dev. 7: 335-343
30. Dokka S., Toledo-Velasquez D., Shi X., Wang L. and Rojanasukul Y. (1997) Cellular delivery of oligonucleotides by synthetic import peptied carrier. Pharmaceut. Res. 14: 1759-1764
31. Morris M. C., Vidal P., Chaloin L., Heitz F. and Divita G. (1997) A new peptide vector for efficient delivery of oligonucleotides into mammalian cells. Nucleic Acids Res. 25: 2730-2736
32. Hariton-Gazal E., Feder R., Graessmann A., Brack-Werner R., Jans D., Gilon C. et al. (2002) Targeting of non-karyophilic cell-permeable peptides into the nuclei of intact cells by covalently attached nuclear localization signals. Biochemistry 41: 9208-9214
33. Benimetskaya L., Guzzo-Pernell N., Liu S.-T., Lai J. C. H., Miller P. and Stein C. A. (2002) Protamine-fragment peptides fused to an SV40 nuclear localization signal deliver oligonucleotides that produce antisense effects in prostate and bladder carcinoma cells. Bioconj. Chem. 13: 177-187
34. Mitchell D. J., Kim D. T., Steinman L., Fathman C. G. and Rothbard J. B. (2000) Polyarginine enters cells more efficiently than other polycationic homopolymers. J. Peptide Res. 56: 318-325
35. Bachmann A. S., Surovoy A., Jung G. and Moelling K. (1998) Integrin receptor-targeted transfer peptides for efficient delivery of antisense oligodeoxynucleotides. J. Mol. Med. 76: 126-132
36. Singh D., Bisland S. K., Kawamura K. and Gariépy J. (1998) Peptide-based intracellular shuttle able to facilitate gene transfer in mammalian cells. Bioconj. Chem. 10: 745-754
37. Tung C.-H. and Stein S. (2000) Preparation and application of peptide-oligonucleotide conjugates. Bioconj. Chem. 11: 605-618
38. Stetsenko D. A., Arzumanov A. A., Korshun V. A. and Gait M. J. (2000) Peptide conjugates of oligonucleotides as enhanced antisense agents: a review. Mol. Biol. 34: 852-859
39. Zubin E. M., Romanova E. A. and Oretskaya T. S. (2002) Modern methods for the synthesis of peptide-oligonucleotide conjugates. Russ. Chem. Rev. 71: 239-264
40. Manoharan M. (2002) Oligonucleotide conjugates as potential antisense drugs with improved uptake, biodistribution, targeted delivery, and mechanism of action. Antisense Nucleic Acid Drug Dev. 12: 103-128
41. Antopolsky M., Azhayeva E., Tengvall U., Auriola S., Jääskeläinen I., Rönkkö S. et al. (1999) Peptide-oligonucleotide phosphorothioate conjugates with membrane translocation and nuclear localization properties. Bioconj. Chem. 10: 598-606
42. Antopolosky M. and Azhayev A. (2000) Stepwise solid-phase synthesis of peptide-oligonucleotide conjugates employing Fmoc peptide chemistry. Tetrahedron Lett 41: 9113-9117
43. Stetsenko D. A., Malakhov A. D. and Gait M. J. (2002) Total stepwise solid-phase synthesis of oligonucleotide (3′-N)-peptide conjugates. Organic Lett. 4: 3259-3262
44. Lemaitre M., Bayard B. and Lebleu B. (1987) Specific antiviral activity of poly (L-lysine)-conjugated oligodeoxyribonucleotide sequence complementary to vesicular stomatitis virus N protein mRNA initiation site. Proc. Natl. Acad. Sci. USA 84: 648-652
45. Leonetti J.-P., Degols G. and Lebleu B. (1990) Biological activity of oligonucleotide-poly (L-lysine) conjugates: mechanism of cell uptake. Bioconj. Chem. 1: 149-153
46. Degols G., Leonetti J.-P., Bekirane M., Devaux C. and Lebleu B. (1992) Poly(L-lysine)-conjugated oligonucleotides promote sequence-specific inhibition of acute HIV-1 infection. Antisense Res. and Dev. 2: 293-301
47. Bongartz J. P., Aubertin A. M., Milhaud P. G. and Lebleu B. (1994) Improved biological activity of antisense oligonucleotides conjugated to a fusogenic peptide. Nucleic Acids Res. 22: 4681-4688
48. Arar K., Aubertin A.-M., Roche A.-C., Monsigny M. and Mayer M. (1995) Synthesis and antiviral activity of a peptide-oligonucleotide conjugates prepared by using Nα-(bromoacetyl)peptides. Bioconj. Chem. 6: 573-577
49. Pichon C., Arar K., Stewart A. J., Dodon M. D., Gazzolo L., Courtoy P. J. et al. (1997) Intracellular routing and inhibitory activity of oligonucleopeptides containing a KDEL motif. Mol. Pharmacol. 51: 431-438
50. Rajur S. B., Roth C. M., Morgan J. R. and Yarmush M. L. (1997) Covalent protein-oligonucleotide conjugates for efficient delivery of antisense molecules. Bioconj. Chem. 8: 935-940
51. Allinquant B., Hantraye P., Mailleux P., Moya K., Bouillot C. and Prochiantz A. (1995) Downregulation of amyloid precursor protein inhibits neurite outgrowth in vitro. J. Cell Biol. 128: 919-927
52. Troy C. M., Derossi D., Prochiantz A., Greene L. A. and Shelanski M. L. (1996) Downregulation of Cu/Zn superoxide dismutase lead to cell death via the nitric oxide-peroxynitrite pathway. J. Neurosci. 16: 253-261
53. Astriab-Fisher A., Sergueev D. S., Fisher M., Ramsay Shaw B. and Juliano R. L. (2000) Antisense inhibition of P-glycoprotein expression using peptide-oligonucleotide conjugates. Biochem. Pharmacol. 60: 83-90
54. Astriab-Fisher A., Sergueev D., Fisher M., Ramsay Shaw B. and Juliano R. L. (2002) Conjugates of antisense oligonucleotides with the Tat and Antennapedia cell-penetrating peptides: effect on cellular uptake, binding to target sequences, and biologic actions. Pharmaceut. Res. 19: 744-754
55. Chaloin L., Vidal P., Lory P., Méry J., Lautredou N., Divita G. et al. (1998) Design of carrier peptide-oligonucleotide conjugates with rapid membrane translocation and nuclear localization properties. Biochem. Biophys. Res. Commun. 243: 601-608
56. Reed M. W., Fraga D., Schwartz D. E., Scholler J. and Hinrichson R. D. (1995) Synthesis and evaluation of nuclear targeting peptide-antisense oligodeoxynucleotide conjugates. Bioconj. Chem. 6: 101-108
57. Zanta M. A., Belguise-Valladier P. and Behr J.-P. (1999) Gene delivery: a single nuclear localization signal peptide is sufficient to carry DNA to the cell nucleus. Proc. Natl. Acad. Sci. USA 96: 91-96
58. Meunier L., Mayer R., Monsigny M. and Roche A. C. (1999) The nuclear export signal-dependent localization of oligonucleopeptides enhances the inhibition of the protein expression from a gene transcribed in the cytosol. Nucleic Acids Res. 27: 2730-2736
59. Basu S. and Wickstrom E. (1997) Synthesis and characterization of a peptide nucleic acid conjugated to a D-peptide analog of insulin-like growth factor 1 for increased cellular uptake. Bioconj. Chem. 8: 481-488
60. Simmons C. G., Pitts A. E., Mayfield L. D., Shay J. W. and Corey D. R. (1997) Synthesis and membrane permiability of PNA-peptide conjugates. Bioorg. Med. Chem. Lett. 7: 3001-3006
61. Kaushik N., Basu A., Palumbo P., Nyers R. L. and Pandey V. N. (2002) Anti-TAR polyamide nucleotide analog conjugated with a membrane-permeating peptide inhibits Human Immunodeficiency Virus Type 1 production. J. Virol. 76: 3881-3891
62. Scarfi S., Giovine M., Gasparini A., Damonte G., Millo E., Pozzolini M. et al. (1999) Modified peptide nucleic acids are internalized in mouse macrophages RAW 264.7 and inhibit inducible nitric oxide synthase. FEBS Lett. 451: 264-268
63. Aldrian-Herrada G., Desarménien M. G., Orcel H., Boissin-Agasse L., Méry J., Brugidou J. et al. (1998) A peptide nucleic acid (PNA) is more rapidly internalized in cultured neurons when coupled to a retro-inverso delivery peptide. The antisense activity depresses the target mRNA and protein in magnocellular oxytocin neurons. Nucleic Acids Res. 26: 4910-4916
64. Cutrona G., Carpaneto E. M., Ulivi M., Roncella S., Landt O., Ferrarini M. et al. (2000) Effects in live cells of a c-myc antigene PNA linked to a nuclear localization signal. Nat. Biotech. 18: 300-303
65. Brandén L. J., Mohamed A. J. and Smith C. I. (1999) A peptide nucleic acids-nuclear localization signal fusion that mediates nuclear transport of DNA. Nat. Biotech. 17: 784-787
66. Brandén L. J., Christensson B. and Smith C. I. E. (2001) In vivo nuclear delivery of oligonucleotides via hybridizing bifunctional peptides. Gene Ther. 8: 84-87
67. Koppelhus U. Awasthi S. K., Zachar V., Holst H. U., Ebbeson P. and Nielsen P. E. (2002) Cell-dependent differential cellular uptake of PNA, peptides and PNA-peptide conjugates. Antisense Nucleic Acid Drug Dev. 12: 51-63
68. Prochiantz A. (1996) Getting hydrophilic compounds into cells: lessons from homeopeptides. Curr. Opin. Neurobiol. 6: 629-634
69. Braun K., Peschke P., Pipkorn R., Lampel S., Wachsmuth M., Waldeck W. et al. (2002) A biological transporter for the delivery of peptide nucleic acids (PNAs) to the nuclear compartment of living cells. J. Mol. Biol. 318: 237-243
70. Richard J. P., Melikov K., Vives E., Ramos C., Verbeure B., Gait M. J. et al. (2003) Cell-penetrating peptides. A re-evaluation of the mechanism of cellular uptake. J. Biol. Chem. 278: 585-590
71. Good L. and Nielsen P. E. (1998) Inhibition of translation and bacterial cell growth by peptide nucleic acid targeted to ribosomal RNA. Proc. Natl. Acad. Sci. USA 95: 2073-2076
72. Good L., Awasthi S. K., Dryselius R., Larsson O. and Nielsen P. E. (2001) Bactericidal antisense effects of peptide-PNA conjugates. Nat. Biotech. 19: 360-364
73. Muratovska A., Ligtowlers R. N., Taylor R. W., Turnbull D. M., Smith R. A. J., Wilce J. A. et al. (2001) Targeting peptide nucleic acid (PNA) oligomers to mitochondria within cells by conjugation to lipohilic cations: implications for mitochondrial DNA replication, expression and disease. Nucleic Acids Res. 29: 1852-1863
74. Corey C. R. (1995) 48000-fold acceleration of hybridisation by chemically modified oligonucleotides. J. Am. Chem. Soc. 117: 9373-9374
75. Elbashir S. M., Martinez J., Patkaniowska A., Lendeckel W. and Tuschl T. (2001) Functional anatomy of siRNAs for mediating efficient RNAi in Drosophila melanogaster embryo lysate. EMBO J. 20: 6877-6888